TCG Crossover raises $600m for debut Asian biotech fund, opens Shanghai and Hong Kong offices
Friday, October 9, 2026 · first reported by AltAssets
TCG Crossover raised $600m for its inaugural dedicated Asian life sciences fund, adding Shanghai and Hong Kong offices.
- Firm
- TCG Crossover
- Fund
- TCG Crossover Asian Life Sciences Fund I
- Size
- $600M
- Stage
- Launch
- Asset class
- Venture
- Geography
- Asia-Pacific
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- Spectrum Equity raises record $2.5bn flagship fund, 25% larger than predecessorAltAssets +3
- Dallas VC firm Disruptive is targeting a $10 billion megafund after Groq bets pay offQuartz
- TCGX Announces Oversubscribed $600 Million Asia FundBusiness Wire
- SEVA Growth nearly doubles debut fund size with $160m close in under a monthAltAssets
- Nabventures Announces First Close Of Rs 450 Cr Second Fund, Targets Rs 1,500 Cr CorpusBW Disrupt +2
- Gaorong Ventures closes $448M Tianjin fund as China's industrial giants step up VC betsCryptoRank